newsfilter
← Latest News
PR Newswire·

PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy

PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it completed the previously announced agreement with Sangamo Therapeutics, Inc. to...